On Monday shares of Athersys, Inc. (NASDAQ:ATHX) closed at $1.33. Company’s sales growth for last 5 years was -6.20% and EPS growth for next 5 years is recorded as 28.00%. Athersys Inc. (NASDAQ:ATHX) on May 11 reported a loss of $12.5 million in its first quarter. The Cleveland-based company said it had a loss of 16 cents per share. Losses, adjusted for non-recurring costs and stock option expense, were 8 cents per share.
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) in last trading activity advanced 0.87% to close at $127.31. Company weekly performance is -0.08% while its quarterly performance stands at 12.01%. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is -7.41% away from its 52 week high. A potential blockbuster drug for cystic fibrosis developed by Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has cleared a major regulatory hurdle, putting it on track to receive final FDA approval this summer. An independent scientific advisory panel on Tuesday recommended the highly anticipated specialty drug Orkambi for FDA approval. Boston-based Vertex projects the new medicine will bring in billions of dollars and help the company reach profitability for only the second year in its 26-year history.
On Monday shares of Atlas Resource Partners, L.P. (NYSE:ARP) closed at $8.40. Company’s sales growth for last 5 years was 5.00% and EPS growth for next 5 years is recorded as 4.00%. Atlas Resource Partners L.P. (NYSE:ARP) on Monday said it has agreed to acquire natural gas producing properties in the Arkoma basin from its parent company, Atlas Energy Group LLC, for $35.5 million.
Envision Healthcare Holdings, Inc. (NYSE:EVHC) has 0.40% insider ownership while its institutional ownership stands at 92.20%. In last trading activity company’s stock closed at $36.58. Envision Healthcare Holdings, Inc. (NYSE:EVHC) participated in Bank of America Merrill Lynch 2015 Healthcare Conference in Las Vegas. Randy Owen, chief financial officer and chief operating officer of Envision present on Wednesday, May 13, 2015, at 4:20 p.m. Pacific Time.
On last trading day SeaWorld Entertainment, Inc. (NYSE:SEAS) advanced 0.56% to close at $21.46. Its volatility for the week is 2.17% while volatility for the month is 2.44%. SEAS’s sales growth for past 5 years was 80.00% and its EPS growth for past 5 years was 22.90%. SeaWorld Entertainment, Inc. (NYSE:SEAS) monthly performance is 5.77%. Wedbush began coverage on shares of SeaWorld Entertainment (NASDAQ:SEAS) in a research note issued on Thursday, TheFlyOnTheWall.com reports. The firm set a “neutral” rating and a $22.00 price target on the stock.